NXU Stock Overview
Nexus AG develops and sells software solutions for the healthcare market in Germany, Switzerland, Liechtenstein, the Netherlands, Poland, France, Austria, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 3/6 |
| Past Performance | 5/6 |
| Financial Health | 6/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for NXU from our risk checks.
Nexus AG Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | €52.40 |
| 52 Week High | €60.60 |
| 52 Week Low | €44.45 |
| Beta | 0.85 |
| 1 Month Change | -6.09% |
| 3 Month Change | -7.91% |
| 1 Year Change | 4.18% |
| 3 Year Change | -8.87% |
| 5 Year Change | 103.89% |
| Change since IPO | 472.68% |
Recent News & Updates
Recent updates
Shareholder Returns
| NXU | DE Healthcare Services | DE Market | |
|---|---|---|---|
| 7D | -6.4% | -3.9% | -2.0% |
| 1Y | 4.2% | -24.7% | -0.3% |
Return vs Industry: NXU exceeded the German Healthcare Services industry which returned -24.7% over the past year.
Return vs Market: NXU exceeded the German Market which returned -0.3% over the past year.
Price Volatility
| NXU volatility | |
|---|---|
| NXU Average Weekly Movement | 3.8% |
| Healthcare Services Industry Average Movement | 4.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.0% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: NXU has not had significant price volatility in the past 3 months.
Volatility Over Time: NXU's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | 1,930 | Ingo Behrendt | www.nexus-ag.de |
Nexus AG develops and sells software solutions for the healthcare market in Germany, Switzerland, Liechtenstein, the Netherlands, Poland, France, Austria, and internationally. The company operates through NEXUS / DE; NEXUS / DIS; and NEXUS / ROE segments. It offers hospital information systems and integrated diagnostic modules that cover various functional requirements of hospitals, psychiatric institutions, rehabilitation facilities, and diagnostic centers, as well as nursing homes.
Nexus AG Fundamentals Summary
| NXU fundamental statistics | |
|---|---|
| Market cap | €935.74m |
| Earnings (TTM) | €24.03m |
| Revenue (TTM) | €245.24m |
38.9x
P/E Ratio3.8x
P/S RatioIs NXU overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| NXU income statement (TTM) | |
|---|---|
| Revenue | €245.24m |
| Cost of Revenue | €175.49m |
| Gross Profit | €69.75m |
| Other Expenses | €45.72m |
| Earnings | €24.03m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
May 14, 2024
| Earnings per share (EPS) | 1.39 |
| Gross Margin | 28.44% |
| Net Profit Margin | 9.80% |
| Debt/Equity Ratio | 0% |
How did NXU perform over the long term?
See historical performance and comparisonDividends
0.4%
Current Dividend Yield16%
Payout RatioDoes NXU pay a reliable dividends?
See NXU dividend history and benchmarks| Nexus dividend dates | |
|---|---|
| Ex Dividend Date | May 16 2024 |
| Dividend Pay Date | May 21 2024 |
| Days until Ex dividend | 23 days |
| Days until Dividend pay date | 28 days |
Does NXU pay a reliable dividends?
See NXU dividend history and benchmarks